Loose Skin and Wegovy: What Happens to Your Skin as You Lose Weight

Why weight loss (fast or slow) affects skin

Skin is elastic, but its capacity to bounce back diminishes with age and is partly fixed by genetics. When fat tissue underneath the skin shrinks, the outer layers need time to remodel. Collagen and elastin, the structural proteins that give skin its firmness, regenerate slowly. If weight comes off faster than those fibres can contract and reorganise, the skin can appear loose, particularly around the abdomen, upper arms, thighs and under the chin.

This happens with any method of significant weight loss, bariatric surgery, very low-calorie diets, or GLP-1 medicines like Wegovy. The semaglutide trials were not designed to measure skin outcomes, so there are no published head-to-head data comparing skin laxity rates between treatment approaches. What the trial data do confirm is that average losses around 15% of starting body weight are achievable, and if you want to hear how that plays out in practice, reading through accounts from people who have used Wegovy gives a useful real-world perspective. At that magnitude, some degree of loose skin is plausible for many people, particularly those who carry significant weight around the abdomen or have had previous pregnancies. Explore the broader picture of how Wegovy affects the skin for more on this.

Age matters considerably. Skin in your forties and fifties contains less elastin than it did two decades earlier, so a 45-year-old losing 20 kg will typically see more laxity than a 28-year-old losing the same amount. Neither outcome is guaranteed, there is genuine biological variability, and some people are surprised by how well their skin adapts.

What the trial evidence can and cannot tell us about Wegovy and loose skin

The STEP programme trials measured body weight, cardiometabolic markers and quality of life. Skin laxity was not a pre-specified endpoint in any of them, so there is no trial-derived figure for how many participants experienced loose skin after Wegovy treatment. This is an honest gap in the published literature rather than reassurance that it doesn't occur.

What the evidence does offer is context. The rate of weight loss on Wegovy tends to be more gradual than post-bariatric results, titration starts at 0.25 mg and progresses over several months toward the maintenance dose, with losses accruing over 68 weeks rather than weeks. That slower trajectory may give skin more time to adapt compared with the steeper early losses seen after gastric bypass. Some clinicians and researchers have noted this theoretically, though direct comparative skin data remain limited.

The NHS semaglutide medicines page lists the recognised side effects of Wegovy; loose skin does not appear there, reinforcing that it is a consequence of the weight loss rather than a pharmacological effect of the drug itself. That distinction matters practically: it means skin changes cannot be prevented by adjusting the dose, and they are not something to report to the Yellow Card scheme as a suspected adverse reaction. For a detailed look at whether Wegovy directly causes loose skin, this question is addressed specifically here.

Factors that make loose skin more or less likely

No single factor determines the outcome, but the following all contribute to how skin responds during and after Wegovy treatment.

Volume of weight lost. The more total weight lost, the greater the potential for laxity. Someone losing 10 kg is unlikely to notice significant change; someone losing 35 kg almost certainly will, in some areas.

Starting skin condition. Stretch marks, sun damage and prior significant weight changes all reduce elasticity before treatment begins.

Muscle mass. Fat sits beneath the skin; muscle provides structure beneath the fat. Preserving or building lean mass through resistance exercise keeps underlying tissue fuller and supports the overlying skin. This is probably the single most modifiable factor during treatment. Our practical Wegovy tips cover exercise and nutrition habits that are worth reading before you begin.

Protein intake. Collagen synthesis depends on adequate protein. Appetite suppression on Wegovy can push protein intake lower than it should be, something to monitor actively with guidance from your prescriber or a dietitian.

Hydration. Well-hydrated skin retains more resilience. It won't prevent laxity, but chronic low fluid intake adds another variable working against you. It is also worth knowing that some people find gut symptoms such as loose stool while taking semaglutide can affect hydration levels, so staying on top of fluid intake is especially important if you experience this.

For strategies to actively support your skin during treatment, this guide to preventing loose skin on Wegovy goes into practical detail.

After treatment: what options exist if loose skin remains

Some skin tightening continues for months after reaching a stable weight, the body keeps remodelling. Most clinicians advise waiting at least a year at a stable weight before considering any cosmetic or surgical assessment, partly because the outcome is still changing and partly because further weight change would affect the result.

Where excess skin causes genuine physical problems (skin infections, rashes beneath skin folds, difficulty with movement or hygiene) surgical options such as abdominoplasty or arm lifts exist and can be considered. These are significant procedures with their own recovery demands and risks, and the decision sits between you and a plastic surgeon rather than with a weight-loss prescriber. They are available privately and, in limited circumstances, through the NHS where functional need is documented.

Non-surgical interventions (radiofrequency, ultrasound devices, topical firming products) have modest and variable evidence. None reverses substantial laxity. They may be useful for mild changes, but approaching them with realistic expectations matters more than the specific product chosen.

If you're considering Wegovy and want to discuss what weight loss at this scale might mean for you personally, start a free consultation with our prescribers, a real clinician reviews your details, not a form-processing algorithm, and they can address concerns like this one.